Pharmacogenetic evaluation to assess breakthrough psychosis with aripiprazole long-acting injection: a case report

Table 1 Patient’s current medication list

Indication	Medication	Dose	Route of Administration
Mental Health
Schizoaffective disorder	Aripiprazole lauroxil	882 mg once a month	IM
Depression	Sertraline	150 mg every morning	PO
Insomnia	Zolpidem CR	12.5 mg at bedtime	PO
Smoking cessation	Varenicline	1 mg BID	PO
Cardiovascular
Hypertension	Amlodipine	10 mg once a day	PO
	Atenolol	50 mg once a day	PO
	Losartan	100 mg once a day	PO
	Spironolactone	100 mg once a day	PO
Prevention of CV disease	Aspirin	81 mg once a day	PO
Type 2 DM
DM	Insulin glargine	120 units BID	SC
	Insulin aspart	As directed	SC
	Metformin	1000 mg BID	PO
Diabetic neuropathy	Gabapentin	1200 mg TID	PO
Respiratory
Asthma	Ipratropium-albuterol	18–103 mcg 2 puffs BID	Nasal
	Albuterol nebulizer	As directed	Nasal
	Budesonide-formoterol	160–4.5 mcg 2 puffs BID	Nasal
Congestion	Fluticasone	50 mcg 1 spray once a day	Nasal
Congestion	Oxymetazoline	0.05% 1 spray every night	Nasal
Pain
Pain	Tramadol	100 mg TID PRN	PO
Gastrointestinal
GERD	Omeprazole	20 mg BID	PO

IM intramuscular, PO by mouth, CR controlled release, BID twice a day, CV cardiovascular, DM diabetes mellitus, SC subcutaneous, TID three times a day, PRN as needed, GERD gastroesophageal reflux disease

ISSN: 1471-244X